Probiotics administered intravaginally as a complementary therapy combined with antibiotics for the treatment of bacterial vaginosis: a systematic review protocol
- PMID: 29038188
- PMCID: PMC5706491
- DOI: 10.1136/bmjopen-2017-019301
Probiotics administered intravaginally as a complementary therapy combined with antibiotics for the treatment of bacterial vaginosis: a systematic review protocol
Abstract
Introduction: Bacterial vaginosis (BV) is a highly prevalent vaginal polymicrobial disorder commonly encountered in women of childbearing age. Therapy with only recommended antibiotics results in low cure rates and unacceptably high recurrence rates. The use of probiotics as a complementary approach for use with antibiotics for the treatment of BV remains unclear. This review aims to assess the efficacy of lactobacilli administered intravaginally in conjunction with antibiotics for the treatment of BV.
Methods and analysis: The Cochrane Central Register of Controlled Trials in The Cochrane Library, Cochrane Library of Systematic Reviews, Medline/PubMed and Embase will be used to search for articles from database inception to November 2016. Randomised controlled clinical trials using lactobacilli administered intravaginally in conjunction with antibiotics to treat BV will be included. Primary outcome will be the BV cure rate. The recurrence rate will be examined as secondary outcome. Two reviewers will independently select trials and extract data from the original publications. The risk of bias will be assessed according to the Cochrane Risk of Bias tool. We will perform data synthesis using the Review Manager (RevMan) software V.5.2.3. To assess heterogeneity, we will compute the I2 statistic.
Ethics and dissemination: This study will be a review of published data and it is not necessary to obtain ethical approval. Findings of this systematic review will be published in a peer-reviewed journal.
Trial registration number: International Prospective Register of Systematic Reviews 2014: CRD42014015079.
Keywords: bacteriology; genitourinary medicine; microbiology; urogynaecology.
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Conflict of interest statement
Competing interests: None declared.
Figures
Similar articles
-
Bacterial vaginosis: a review on clinical trials with probiotics.New Microbiol. 2013 Jul;36(3):229-38. Epub 2013 Jun 30. New Microbiol. 2013. PMID: 23912864 Review.
-
Restoring vaginal microbiota: biological control of bacterial vaginosis. A prospective case-control study using Lactobacillus rhamnosus BMX 54 as adjuvant treatment against bacterial vaginosis.Arch Gynecol Obstet. 2016 Jan;293(1):101-107. doi: 10.1007/s00404-015-3810-2. Epub 2015 Jul 5. Arch Gynecol Obstet. 2016. PMID: 26142892
-
Probiotics are a good choice for the treatment of bacterial vaginosis: a meta-analysis of randomized controlled trial.Reprod Health. 2022 Jun 13;19(1):137. doi: 10.1186/s12978-022-01449-z. Reprod Health. 2022. PMID: 35698149 Free PMC article. Review.
-
[Use of probiotics in bacterial vaginosis].Semergen. 2017 Jul-Aug;43(5):394-398. doi: 10.1016/j.semerg.2016.09.002. Epub 2016 Nov 14. Semergen. 2017. PMID: 27856152 Review. Spanish.
-
Antifungal (oral and vaginal) therapy for recurrent vulvovaginal candidiasis: a systematic review protocol.BMJ Open. 2019 May 22;9(5):e027489. doi: 10.1136/bmjopen-2018-027489. BMJ Open. 2019. PMID: 31122991 Free PMC article.
Cited by
-
Evaluation of vaginal microbiome equilibrium states identifies microbial parameters linked to resilience after menses and antibiotic therapy.PLoS Comput Biol. 2023 Aug 11;19(8):e1011295. doi: 10.1371/journal.pcbi.1011295. eCollection 2023 Aug. PLoS Comput Biol. 2023. PMID: 37566641 Free PMC article.
-
Advancements in the Pharmaceutical Applications of Probiotics: Dosage Forms and Formulation Technology.Int J Nanomedicine. 2021 Nov 12;16:7535-7556. doi: 10.2147/IJN.S337427. eCollection 2021. Int J Nanomedicine. 2021. PMID: 34795482 Free PMC article. Review.
-
The Immunomodulatory Properties of Extracellular Vesicles Derived from Probiotics: A Novel Approach for the Management of Gastrointestinal Diseases.Nutrients. 2019 May 9;11(5):1038. doi: 10.3390/nu11051038. Nutrients. 2019. PMID: 31075872 Free PMC article. Review.
-
Acceptability of and treatment preferences for recurrent bacterial vaginosis-Topical lactic acid gel or oral metronidazole antibiotic: Qualitative findings from the VITA trial.PLoS One. 2019 Nov 15;14(11):e0224964. doi: 10.1371/journal.pone.0224964. eCollection 2019. PLoS One. 2019. PMID: 31730666 Free PMC article. Clinical Trial.
-
Detection of vaginal lactobacilli as probiotic candidates.Sci Rep. 2019 Mar 4;9(1):3355. doi: 10.1038/s41598-019-40304-3. Sci Rep. 2019. PMID: 30833631 Free PMC article.
References
-
- Walker J, Hocking JS, Fairley CK, et al. The prevalence and incidence of bacterial vaginosis in a cohort of young Australian women In:Conference proceedings of the International Society for Sexually Transmitted Diseases Research Quebec, Canada, 2011. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical